-
Gene therapy can partly restore sight in people with retinitis pigmentosa, researchers reveal
Medical Mythbusting Commentary for October 9, 2026 Source:Gene therapy can partly restore sight in blind people, researchers reveal Reference:Optogenetic Therapy for Restoring Aspects of Visual Function
-
Our brain and attention may change how our immune system responds to inflammation
Medical Mythbusting Commentary for October 8, 2026 Source:Focusing your attention may help your brain fight inflammation, study suggests Reference:Voluntary attention regulates acute immune responses in humans
-
Tapeworm Treatment, Niclosamide, Shows Early Effectiveness Against Endometriosis
Medical Mythbusting Commentary for October 7, 2026 Source:Tapeworm Treatment Shows Early Effectiveness Against Endometriosis Reference:2-Deoxyglucose Dendrimer-Enabled Niclosamide Delivery to FRβ-Expressing Macrophages Alleviates Endometriosis Progression and Associated Hyperalgesia
-
New approach to treating metastatic pancreatic adenocarcinoma for people who already had at least one systemic treatment, or who cannot take multi-drug chemotherapy.
Medical Mythbusting Commentary for October 1, 2026 Source:This Pill Will Change Cancer Treatment Forever Reference:Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer,
-
Scientists test epigenetic marker tests to determine if they provide useful information about biological systems that drive human aging.
Medical Mythbusting Commentary for September 29, 2026 Source:Scientists Put Anti-Aging Treatments to the Test – These Ones Actually Changed Biological Age Reference:Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
-
Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders
Medical Mythbusting Commentary for September 25, 2026 Source:Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders Reference:Prenatal exposure to paracetamol and the risk of autism and attention‐deficit/hyperactivity disorder: An umbrella review and meta‐meta‐analysis.
-
Optimism is the word given the breadth and depth of research and phase 3 studies evaluating potential treatments for Alzheimer’s Disease.
Medical Mythbusting Commentary for September 23, 2026 Source:Alzheimer’s Is No Longer an Untreatable Disease, Major Report Concludes. Here’s Why.
-
This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients With Smoldering Multiple Myeloma– Before They Even Got Cancer
Medical Mythbusting Commentary for September 22, 2026 Source:This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients – Before They Even Got Cancer Reference:Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
-
Scientists Used Cancer Therapy To Reset Rheumatoid Arthritis in Small Phase 1 Study
Medical Mythbusting Commentary for September 17, 2026 Source:Scientists Used Cancer Therapy To Reset Rheumatoid Arthritis Reference:CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial